Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cervical Cancer|Prostate Cancer Metastatic|Breast Cancer|Colon Cancer|NSCLC|Cutaneous Melanoma
Interventions: DRUG: ²¹²Pb-DOTAM-GRPR1
Sponsor: Orano Med LLC